The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a potential advance. Unlike injections, this method offers a less invasive way to deliver GLP-1 drugs. These https://arunuikl945070.blogginaway.com/41721404/glp-1-patches-a-innovative-approach-to-blood-sugar-management